Back to top
more

Roche Holding AG (RHHBY)

(Delayed Data from OTC)

$41.08 USD

41.08
1,213,280

-1.03 (-2.45%)

Updated Oct 21, 2020 03:59 PM ET

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.33%
2Buy17.77%
3Hold9.37%
4Sell4.88%
5Strong Sell1.79%
S&P50010.56%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value A Growth D Momentum A VGM

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 33% (170 out of 254)

Industry: Large Cap Pharmaceuticals

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for RHHBY

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Roche Holding AG falls in the month of December.

All items in Millions except Per Share data.

12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Assets          
Cash & Equivalents 11,935 13,412 12,193 9,246 9,544
Receivables 10,508 9,995 9,733 8,894 8,668
Notes Receivable 0 0 0 0 0
Inventories 6,094 6,769 7,528 8,049 7,959
Other Current Assets 2,920 2,790 2,633 2,919 3,157
Total Current Assets 31,457 32,966 32,087 29,109 29,329
Net Property & Equipment 22,317 22,307 21,253 20,262 19,225
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 5,245 3,982 3,634 2,869 2,668
Intangibles 20,949 18,704 18,746 23,685 25,958
Deposits & Other Assets 2,510 2,317 2,206 2,069 1,666
Total Assets 83,631 80,276 77,926 77,994 78,847
Liabilities & Shareholders Equity 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Notes Payable 0 0 0 0 0
Accounts Payable 3,847 3,605 3,510 3,427 3,338
Current Portion Long-Term Debt 1,706 2,753 3,172 5,445 6,401
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 3,863 3,893 3,464 2,755 2,894
Other Current Liabilities 14,860 13,297 12,375 11,320 12,102
Total Current Liabilities 24,276 23,549 22,521 22,946 24,735
Mortgages 0 0 0 0 0
Deferred Taxes/Income 300 393 503 851 567
Convertible Debt 0 0 0 0 0
Long-Term Debt 12,750 16,437 16,097 17,252 17,796
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 10,205 8,851 9,325 10,140 11,500
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 47,531 49,230 48,446 51,188 54,598
Shareholders Equity 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Preferred Stock 0 0 0 0 0
Common Stock (Par) 161 164 163 162 167
Capital Surplus 0 0 0 0 0
Retained Earnings 40,787 35,718 33,808 31,568 29,755
Other Equity -4,848 -4,835 -4,491 -4,924 -5,673
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 36,100 31,046 29,480 26,806 24,248
Total Liabilities & Shareholder's Equity 83,631 80,276 77,926 77,994 78,847
Total Common Equity 36,100 31,046 29,480 26,806 24,248
Shares Outstanding 6,848.40 6,833.30 6,830.70 6,815.40 6,816.10
Book Value Per Share 5.27 4.54 4.32 3.93 3.56

Fiscal Year End for Roche Holding AG falls in the month of December.

All items in Millions except Per Share data.

9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019
Assets          
Cash & Equivalents NA 6,488 NA 11,935 NA
Receivables NA 12,106 NA 10,508 NA
Notes Receivable NA NA NA 0 NA
Inventories NA 7,043 NA 6,094 NA
Other Current Assets NA 3,111 NA 2,920 NA
Total Current Assets NA 28,747 NA 31,457 NA
Net Property & Equipment NA 22,898 NA 22,317 NA
Investments & Advances NA NA NA 0 NA
Other Non-Current Assets NA NA NA 0 NA
Deferred Charges NA 5,260 NA 5,245 NA
Intangibles NA 22,314 NA 20,949 NA
Deposits & Other Assets NA 2,948 NA 2,510 NA
Total Assets NA 83,393 NA 83,631 NA
Liabilities & Shareholders Equity 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019
Notes Payable NA NA NA 0 NA
Accounts Payable NA 3,157 NA 3,847 NA
Current Portion Long-Term Debt NA 2,648 NA 1,706 NA
Current Portion Capital Leases NA NA NA 0 NA
Accrued Expenses NA NA NA 0 NA
Income Taxes Payable NA 4,398 NA 3,863 NA
Other Current Liabilities NA 13,107 NA 14,860 NA
Total Current Liabilities NA 23,310 NA 24,276 NA
Mortgages NA NA NA 0 NA
Deferred Taxes/Income NA 312 NA 300 NA
Convertible Debt NA NA NA 0 NA
Long-Term Debt NA 12,962 NA 12,750 NA
Non-Current Capital Leases NA NA NA 0 NA
Other Non-Current Liabilities NA NA 10,205 NA
Minority Interest (Liabilities) NA NA NA 0 NA
Total Liabilities NA 47,265 NA 47,531 NA
Shareholders Equity 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019
Preferred Stock NA NA NA 0 NA
Common Stock (Par) NA 166 NA 161 NA
Capital Surplus NA NA NA 0 NA
Retained Earnings NA 41,317 NA 40,787 NA
Other Equity NA -5,356 NA -4,848 NA
Treasury Stock NA NA NA 0 NA
Total Shareholder's Equity NA 36,128 NA 36,100 NA
Total Liabilities & Shareholder's Equity NA 83,393 NA 83,631 NA
Total Common Equity 0 136,127 0 36,100 0
Shares Outstanding 6,848.40 6,848.40 6,848.40 6,848.40 6,848.40
Book Value Per Share 0.00 19.88 0.00 5.27 0.00